JAK3 and B-cell chronic lymphocytic leukemia: In CD40-stimulated B-CLL cells, IL-21 activated JAK1 and JAK3, with the consequent phosphorylation of STAT1, STAT3, and STAT5, and it increased the programmed cell death of B-CLL cells.